Rankings
▼
Calendar
AMRN Q1 2022 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$95M
-33.4% YoY
Gross Profit
$72M
76.5% margin
Operating Income
-$28M
-29.9% margin
Net Income
-$32M
-33.4% margin
EPS (Diluted)
$-1.59
QoQ Revenue Growth
-34.5%
Cash Flow
Operating Cash Flow
-$98M
Free Cash Flow
-$98M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$974M
Total Liabilities
$333M
Stockholders' Equity
$641M
Cash & Equivalents
$219M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$95M
$142M
-33.4%
Gross Profit
$72M
$114M
-36.4%
Operating Income
-$28M
-$1M
-2026.7%
Net Income
-$32M
-$2M
-1841.1%
Revenue Segments
Product
$94M
99%
Licensing And Royalty
$644,000
1%
← FY 2022
All Quarters
Q2 2022 →